Skip to main content

AptarGroup, Inc. (ATR)

NYSE: ATR · IEX Real-Time Price · USD
120.82 0.54 (0.45%)
Dec 8, 2021 4:00 PM EST - Market closed
Market Cap7.95B
Revenue (ttm)3.16B
Net Income (ttm)239.72M
Shares Out65.83M
EPS (ttm)3.54
PE Ratio34.12
Forward PE26.95
Dividend$1.50 (1.24%)
Ex-Dividend DateOct 26, 2021
Volume207,393
Open120.60
Previous Close120.28
Day's Range119.46 - 121.27
52-Week Range116.67 - 158.97
Beta0.67
AnalystsBuy
Price Target147.14 (+21.8%)
Earnings DateOct 28, 2021

About ATR

AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary pack...

IndustryContainers & Packaging
IPO DateApr 21, 1993
CEOStephan Tanda
Employees13,000
Stock ExchangeNYSE
Ticker SymbolATR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for AptarGroup stock is "Buy." The 12-month stock price forecast is 147.14, which is an increase of 21.78% from the latest price.

Price Target
$147.14
(21.78% upside)
Analyst Consensus: Buy

News

Aptar in Top 10 of America's Most Responsible Companies 2022 by Newsweek

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions, has been named one of America's Most Respo...

6 days ago - Business Wire

Aptar Named One of the Most Responsible Companies in France by Le Point

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions is named one of the Most Responsible Compan...

1 week ago - Business Wire

BERY vs. ATR: Which Stock Is the Better Value Option?

BERY vs. ATR: Which Stock Is the Better Value Option?

Other symbols:BERY
2 weeks ago - Zacks Investment Research

Aptar Tops the Forbes Green Growth 50 List

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions, announced today that it has been ranked #1...

2 weeks ago - Business Wire

AMCR or ATR: Which Is the Better Value Stock Right Now?

AMCR vs. ATR: Which Stock Is the Better Value Option?

Other symbols:AMCR
1 month ago - Zacks Investment Research

Aptar Named a Global Top 10 Female-Friendly Company by Forbes

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named a Global Top 10 Female-Friendly Company by Forbes

1 month ago - Business Wire

AptarGroup (ATR) Meets Q3 Earnings Estimates

AptarGroup (ATR) delivered earnings and revenue surprises of 0.00% and 0.98%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

AptarGroup: Q3 Earnings Insights

AptarGroup (NYSE:ATR) reported its Q3 earnings results on Thursday, October 28, 2021 at 05:00 PM. Here's what investors need to know about the announcement.

1 month ago - Benzinga

Aptar Reports Third Quarter 2021 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported third quarter result...

1 month ago - Business Wire

First Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar's Nasal Pump Sy...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today announced that its patented C...

1 month ago - Business Wire

Analysts Estimate AptarGroup (ATR) to Report a Decline in Earnings: What to Look Out for

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Aptar Declares Quarterly Dividend

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash di...

1 month ago - Business Wire

GEF or ATR: Which Is the Better Value Stock Right Now?

GEF vs. ATR: Which Stock Is the Better Value Option?

Other symbols:GEF
1 month ago - Zacks Investment Research

Are Shares Of AptarGroup Ready To Rip Higher?

Shares of AptarGroup, Inc. (NYSE:ATR) are oversold and at support. That means there's a good chance they rally or rebound.

2 months ago - Benzinga

GEF vs. ATR: Which Stock Is the Better Value Option?

GEF vs. ATR: Which Stock Is the Better Value Option?

Other symbols:GEF
2 months ago - Zacks Investment Research

New Strong Sell Stocks for September 14th

ATR, FTAI, HGEN, LMB, and MRSN have been added to the Zacks Rank #5 (Strong Sell) List on September 14, 2021.

Other symbols:FTAIHGENLMBMRSN
2 months ago - Zacks Investment Research

Aptar to Host Virtual Capital Markets Day

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, will host a virtual Capital Market...

2 months ago - Business Wire

Aptar Mourns Death of Longtime Board Member, Dr. Joanne Smith

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR) today announced with great sadness that Dr. Joanne Smith, a valued longtime member of the Board of Directors, has passed away. “Joanne w...

3 months ago - Business Wire

AptarGroup (ATR) Buys Stake in Voluntis, Boosts Capabilities

AptarGroup (ATR) completes the acquisition of 64.6% stake in Voluntis, which will help expand its digital healthcare offerings and drive innovation in the healthcare space.

3 months ago - Zacks Investment Research

Aptar Announces the Completion of the Acquisition of a Majority Stake in Voluntis

CRYSTAL LAKE, III.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that following the...

3 months ago - Business Wire

Inflation Nation: Focus on packaging inflation

Salvatore Tiano, Seaport Research Partners, joins Power Lunch to discuss inflation in packaging costs and how it could impact consumers and businesses. For access to live and exclusive video from CNBC s...

Other symbols:AMCRBLLOISLGNSON
3 months ago - CNBC Television

GEF vs. ATR: Which Stock Should Value Investors Buy Now?

GEF vs. ATR: Which Stock Is the Better Value Option?

Other symbols:GEF
3 months ago - Zacks Investment Research

AptarGroup (ATR) Shares Decline as Q2 Earnings Lag Estimates

AptarGroup's (ATR) second-quarter 2021 top line improves on increased demand for the company's dispensing solutions.

4 months ago - Zacks Investment Research

AptarGroup Reports Mixed Q2 Results, Sees Q3 EPS Below Consensus

AptarGroup Inc (NYSE: ATR) reported second-quarter FY21 sales growth of 15.9% year-on-year, to $811.03 million, beating the analyst consensus of $774.81 million. The Core sales, excluding currency effec...

4 months ago - Benzinga

AptarGroup (ATR) Q2 Earnings Lag Estimates

AptarGroup (ATR) delivered earnings and revenue surprises of -6.19% and 4.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research